Safety and Efficacy of the Surpass Evolve Flow Diverter in Treating Intracranial Aneurysms

Active, not recruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

November 29, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions

Intracranial Arterial Aneurysm

Interventions

DEVICE

Flow diverting

Flow diverter has become the standardized treatment method for Intracranial aneurysms (IAs), which is different from angioplasty, coiling, etc.

Trial Locations (1)

Shanghai Fourth People's Hospital, Shanghai

All Listed Sponsors

lead

Yibin Fang

OTHER

NCT06731946 - Safety and Efficacy of the Surpass Evolve Flow Diverter in Treating Intracranial Aneurysms | Biotech Hunter | Biotech Hunter